Extera Partners is a company.
Key people at Extera Partners.
Extera Partners was founded by Vikas Goyal (Senior Associate, Co-Founder).
Key people at Extera Partners.
Extera Partners was founded by Vikas Goyal (Senior Associate, Co-Founder).
Extera Partners is a venture capital and corporate development firm specializing in the life sciences sector, particularly biotechnology and medical devices. Their mission centers on investing in and building companies that improve clinical outcomes, enhance quality of life, and reduce healthcare costs. They leverage a unique combination of deal flow, industry expertise, financing resources, and a strong network of family offices and institutional investors to generate substantial financial returns and strategic growth for their portfolio companies[1][2].
Founded in 2007 initially as a corporate development advisory firm, Extera Partners evolved into an investment and venture creation firm focused on life sciences. The firm is led by Jonathan Reis, its founder and managing partner, who brings extensive experience from companies like Censa Pharmaceuticals, Acer Therapeutics, and PureTech. Over time, Extera has expanded its focus from advisory services to active investment and company building in biotechnology and medical devices, capitalizing on its deep industry knowledge and network[1][3].
Extera Partners rides the growing trend of specialized investment in life sciences, a sector driven by increasing demand for innovative healthcare solutions and cost-effective medical technologies. The timing aligns with global healthcare challenges and technological advancements in biotechnology and medical devices. By bridging capital, expertise, and strategic advisory, Extera influences the broader ecosystem by accelerating the development and commercialization of impactful healthcare innovations[1][2].
Looking ahead, Extera Partners is poised to continue leveraging its unique model to identify and build high-potential life sciences ventures. Trends such as personalized medicine, digital health integration, and cost containment in healthcare will likely shape their investment focus. Their influence may grow as they deepen their role in scaling companies that address critical healthcare needs, potentially expanding their geographic reach and sector breadth within life sciences[1][3]. This positions Extera as a key player in transforming healthcare through strategic investment and company creation.
